Bausch Health Companies (BHC) Common Equity (2009 - 2026)
Bausch Health Companies (BHC) posted Common Equity of -$1.8 billion for Q2 2026, down 63.68% sequentially from -$1.1 billion in Q1 2026, and down 1304.76% YoY from $147.0 million in Q2 2025.
Bausch Health Companies (BHC) Common Equity (2009 - 2026) Analysis & Trends
Bausch Health Companies has reported Common Equity for 18 years, with the latest figure at -$1.8 billion in Q2 2026.
- Quarterly Common Equity fell 1304.76% year-over-year to -$1.8 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$1.8 billion (down 1304.76% YoY) and the FY2025 annual result came in at -$554.0 million, up 56.68% from the prior year.
- Common Equity declined to -$1.8 billion in Q2 2026 per BHC's latest filing, from -$1.1 billion in the prior quarter.
- Over five years, Common Equity peaked at $433.0 million in Q3 2022 and troughed at -$1.8 billion in Q2 2026.
- A 5-year average of -$282.4 million and a median of -$200.5 million in 2024 frame the typical range for Common Equity.
- The sharpest annual moves came in 2022 and 2024: Common Equity jumped 864.71% in 2022, then slumped 1459.76% in 2024.
- Over 5 years, Common Equity stood at $260.0 million in 2022, then plunged by 131.54% to -$82.0 million in 2023, then plunged by 1459.76% to -$1.3 billion in 2024, then surged by 56.68% to -$554.0 million in 2025, then tumbled by 219.68% to -$1.8 billion in 2026.
- According to Business Quant data, Common Equity over the past three periods registered -$1.8 billion, -$1.1 billion, and -$554.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.45 Bn | 43.48 Bn | - | 22.06 Bn |
| 2 | Teva Pharmaceutical Industries | 43.73 Bn | 40.07 Bn | 2.15 Bn | 7.76 Bn |
| 3 | Zoetis | 32.51 Bn | 30.83 Bn | 1.05 Bn | 3.15 Bn |
| 4 | Takeda Pharmaceutical | 28.62 Bn | 22.82 Bn | 5.10 Bn | 47.42 Bn |
| 5 | United Therapeutics | 21.98 Bn | 19.32 Bn | 683.80 Mn | 6.40 Bn |
| 6 | Viatris | 19.01 Bn | 18.13 Bn | 1.46 Bn | 14.26 Bn |
| 7 | Neurocrine Biosciences | 15.54 Bn | 15.15 Bn | 935.80 Mn | 3.69 Bn |
| 8 | Elanco Animal Health | 11.98 Bn | 11.45 Bn | 798.00 Mn | 6.59 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 4.05 Bn |
| 10 | Bausch Health Companies | 2.44 Bn | 603.25 Mn | 2.10 Bn | -1.77 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.77 Bn |
| Mar 31, 2026 | -1.08 Bn |
| Dec 31, 2025 | -554.00 Mn |
| Sep 30, 2025 | 356.00 Mn |
| Jun 30, 2025 | 147.00 Mn |
| Mar 31, 2025 | -240.00 Mn |
| Dec 31, 2024 | -322.00 Mn |
| Sep 30, 2024 | -242.00 Mn |
| Jun 30, 2024 | -227.00 Mn |
| Mar 31, 2024 | -174.00 Mn |
| Dec 31, 2023 | -82.00 Mn |
| Sep 30, 2023 | -235.00 Mn |
| Jun 30, 2023 | 271.00 Mn |
| Mar 31, 2023 | 145.00 Mn |
| Dec 31, 2022 | 260.00 Mn |
| Sep 30, 2022 | 433.00 Mn |
| Jun 30, 2022 | 253.00 Mn |
| Mar 31, 2022 | -141.00 Mn |
| Dec 31, 2021 | -34.00 Mn |
| Sep 30, 2021 | -135.00 Mn |